$36,655,675

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

ACTION DATE2026-03-27·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50122C00070_7505_-NONE-_-NONE-

Award description

THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO DEVELOP AND COMMERCIALIZE A RAPID PHENOTYPIC ANTIMICROBIAL SUSCEPTIBILITY TESTING (AST) SYSTEM THAT WILL DELIVER RESULTS FOR DEFINITIVE THERAPEUTIC DECISIONS WITHIN 4 TO 6 HOURS FROM COLONIES ON A CULTURE

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Develop a rapid antimicrobial susceptibility testing system delivering diagnostic results within 4-6 hours to guide antibiotic treatment decisions.

Sub-sectors

antimicrobial-susceptibility-testingdiagnostic-device-developmentpandemic-preparedness

Why this matters

Accelerates clinical decision-making for infections, reducing inappropriate antibiotic use and combating antimicrobial resistance—a critical public health threat.

Supply-chain signal

Signals demand for diagnostic instrumentation and reagent suppliers supporting rapid microbiology platforms in clinical laboratories.

U.S.–China competition angle

Rapid AST systems are strategic for pandemic preparedness and infection control; dominance in diagnostic technology is a key U.S.-China biotech competition area.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002400.

Period of performance

Start

2022-09-30

End

2026-09-29

Status

activein 137 days

Recipient

BECKMAN COULTER, INC

UEI PU6HHX2R11C7

View full profile →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50122C00070_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.